Effect of Danhong injection on pharmacokinetics and pharmacodynamics of rivaroxaban in rats

Weihong Yin,Jiao Li,Zhaoyang Han,Siwen Wang,Fan Wu,Chao Yu,Xueying Yan,Mingyu Cui
DOI: https://doi.org/10.1007/s00210-024-03453-5
2024-10-02
Naunyn-Schmiedeberg s Archives of Pharmacology
Abstract:Rivaroxaban is often used in combination with DHI to treat thromboembolic disease. Whether the combination causing HDIs is still unknown. The purpose of this study was to evaluate effects of DHI on pharmacokinetics and pharmacodynamics of rivaroxaban in rats and effects on CYP3A2.
pharmacology & pharmacy
What problem does this paper attempt to address?